Krakow Krakow Krakow Krakow Krakow Krakow Krakow

2nd Central European Biomedical Congress


15-18 June 2016


Kraków (Krakow), Poland

Registration
CEBC2016 logo

Welcome Address


Dear Colleague,

Continuous progress in biomedicine and pharmacology allows us to believe that personalized medicine, i.e., medicine precisely tailored for the individual patient, will become a clinical routine. Thus, the title of the 2nd Central European Biomedical Congress (CEBC) is: "From emerging biochemical strategies to personalized medicine".

The Congress is held in Kraków, Poland on June 15-18, 2016.

The 2nd CEBC is designed to bring together clinicians, physicians, pharmacologists, biologists, biotechnologists, and students. Top international speakers will provide insight into the latest findings and development in clinical practice, preclinical research and technology. The Congress also promotes outstanding opportunities for junior scientists to present research and interact with leaders in the field.

Kraków is more than just another nice city. This legendary city is the old capital of Poland placed on UNESCO’s list of World Cultural Heritage. The city is famous for its hospitality, beautiful architecture and cultural attractions.

We look forward to greeting you at CEBC in Kraków.

Best regards,

Organizing Committee

Małgorzata Filip

Edmund Przegaliński

Institute of Pharmacology
Polish Academy of Sciences
Kraków

Marek Sanak

Joanna Pera

Faculty of Medicine
Jagiellonian University, College of Medicine
Kraków

About the Event


The Central European Biomedical Congress (CEBC) mission is to address important health problems between the “bench and bedside” and invites all physicians, clinicians, pharmacists, biologists, biotechnologists, pharmacologists as well as other allied health professionals from Europe and beyond. The Congress also promotes outstanding opportunities for junior scientists (graduate students and Ph.D. students) to present research and interact with leaders in the field.

The 2nd CEBC, themed “From emerging biochemical strategies to personalized medicine”, will be hosted by Institute of Pharmacology Polish Academy of Sciences and the Faculty of Medicine Jagiellonian University College of Medicine (Kraków, Poland).

We are pleased to announce that Rector of the Jagiellonian University Professor Wojciech Nowak and President of the Polish Academy of Sciences Professor Jacek Duszyński have assumed the Honorary Patronage over the Congress.

The Scientific Committee invited top international speakers to provide insight into the latest findings and development in clinical practice, preclinical research and technology.
Four days of the Congress include plenary lectures, symposia and interactive workshops. Young scientists are especially encouraged to present their recent findings through free communications and posters presentations.

Our invitation for the plenary lectures accepted:


  • Kalpana M. Merchant - Indiana University-Purdue University, USA

    Inaugural lecture: Personalized therapies for CNS diseases: needs and approaches

  • Jan Lubiński - Pomeranian Medical University, Poland

    Plenary lecture: Hereditary breast and ovarian cancers

  • Herbert Y. Meltzer - Northwestern University, USA

    Plenary lecture: Personalizing treatment of the schizophrenia spectrum through endophenotypes, rational pharmacology, and pharmacogenomics

  • Brian Kobilka, the Nobel Prize laureate - Stanford University, USA

    Plenary lecture: Structural insights into G protein coupled receptor activation

  • Anton Bespalov - Partnership for Assessment and Accreditation of Scientific Practice, Germany

    Plenary lecture: How novel should the new drug targets be? Industry perspective

  • Kjell Fuxe - Karolinska Institute, Sweden

    Plenary lecture: Heteroreceptor complexes and their allosteric receptor-receptor interactions as a novel biological principle for integration of communication in the CNS: targets for drug development in mental and neurological disorders

Check Program

Session Tracks

in alphabetical order


Clinical research

Cerebrovascular diseases

Chairs: Jerzy Krupiński (Spain ), Agnieszka Słowik (Poland )

Diabetes

Chairs: Maciej Małecki (Poland )

Novel mechanisms and mediators in allergic inflammation

Chairs: Marek Sanak (Poland )

Personalized medicine

Chairs: Zbigniew Gaciong (Poland ), Tomasz Grodzicki (Poland )

Recent advances in the clinical applications of stem cells

Chairs: Yang D. Teng (USA ), Marcin Majka (Poland )

Preclinical research

Environmental conditions and neuropsychiatric disorders

Chairs: Anni-Maija Linden (Finland ), Marzena Maćkowiak (Poland )

From Lipids to Serotonin: Advancing toward novel therapeutics for addictive disorders

Chairs: Kathryn A. Cunningham (USA ), Edmund Przegaliński (Poland )

Learning the emotions with the help of the amygdala

Chairs: Ewelina Knapska (Poland ), Leszek Kaczmarek (Poland )

Looking for new targets for medicinal chemistry-academic perspective

Chairs: Kenneth A. Jacobson (USA ), Katarzyna Kieć-Kononowicz (Poland )

Nanomedicine

Chairs: Vladimir P. Torchilin (USA ), Piotr Warszyński (Poland )

Neurodegenerative diseases

Chairs: Jacek Kuźnicki (Poland )

Neuroimmunological aspect of pain

Chairs: Joanna Mika (Poland )

Society of Neurotoxicity - Processes and Mechanisms Associated with Parkinson’s Disease

Chairs: Richard M. Kostrzewa (USA ), Elaine Del Bel Guimaraes (Brasil )

Potential therapeutic targets suggested by animal models of brain diseases

Chairs: Vincenco Cesari (Italy ), Irena Nalepa (Poland )

Property-based drug design (pharmaceutical companies’ point of view)

Chairs: Małgorzata Filip (Poland )

Structure-based drug design

Chairs: Andrzej Bojarski (Poland )

Organizers Notice


The Conference theme provides opportunities for researchers to share their work with colleagues in their area of interest and with researchers in allied fields.

The official language of the Congress is English. No simultaneous translation will be provided.

Deadline for Early Registration is March 30, 2016

Registration discounts are offered to junior scientists (graduate students, Ph.D. students and Ph.D. fellows below the age of 35), and those registering before March 11, 2016.

Deadline for Abstract submission is April 15, 2016

Important message: Polish health professionals attending the Congress are eligible for credit points.

Our Sponsors


We are very thankful to our sponsors, without whom our conference would not be possible:

Patronage




Honorary Patronage


We are very pleased to announce that following persons took the honorary patronage over the 2nd Central European Biomedical Congress:



Jacek Majchrowski
Jacek Majchrowski

Professor, Ph.D.


Mayor
Royal Capital City of Krakow
 

Wojciech Nowak
Wojciech Nowak

Professor, Ph.D., M.D.


Rector
Jagiellonian University
 

Jerzy Duszyński
Jerzy Duszyński

Professor, Ph.D.


President
Polish Academy of Sciences
 



Honorary Committee




Piotr Laidler
Piotr Laidler

Professor, Ph.D.


Vice-Rector
Collegium Medicum
Jagiellonian University

Krzysztof Wędzony
Krzysztof Wędzony

Professor, Ph.D.


Director
Institute of Pharmacology
Polish Academy of Sciences

Tomasz Grodzicki
Tomasz Grodzicki

Professor, Ph.D., M.D.


Dean of the Faculty of Medicine
Collegium Medicum
Jagiellonian University

Media


Kraków.pl
Okręgowa Izba Aptekarska
FarmacjaNET
FarmacjaPL
MgrFarm
e-Dukacja
e-Farmacja
Biotechnologia

Scientific Committee




Name Institution Country
Andrzej Bojarski
Professor, Ph.D.
Institute of Pharmacology, Polish Academy of Sciences
Krakow
Poland
Kathryn A. Cunningham
Professor, Ph.D.
Center for Addiction Research & Department of Pharmacology and Toxicology
UTMB, Galveston, TX
United States of America
Małgorzata Filip
Professor, Ph.D.
Institute of Pharmacology, Polish Academy of Sciences
Krakow
Poland
Kjell Fuxe
Professor, Ph.D., M.D.
Department of Neuroscience, Karolinska Institute
Stockholm
Sweden
Zbigniew Gaciong
Professor, Ph.D., M.D.
Faculty of Medicine, Medical University of Warsaw
Warsaw
Poland
Leszek Kaczmarek
Professor, Ph.D.
Nencki Institute of Experimental Biology, Polish Academy of Sciences
Warsaw
Poland
Richard M. Kostrzewa
Professor, Ph.D.
East Tennessee State University USA
Katarzyna Kieć-Kononowicz
Professor, Ph.D.
Collegium Medicum, Jagiellonian University
Krakow
Poland
Jacek Kuźnicki
Professor, Ph.D.
International Institute of Molecular and Cellular Biology
Warsaw
Poland
Władysław Lasoń
Professor, Ph.D.
Institute of Pharmacology, Polish Academy of Sciences
Krakow
Poland
Marzena Maćkowiak
Associate Professor, Ph.D.
Institute of Pharmacology, Polish Academy of Sciences
Krakow
Poland
Marcin Majka
Professor, Ph.D., M.D.
Collegium Medicum, Jagiellonian University
Krakow
Poland
Maciej Małecki
Professor, Ph.D., M.D.
Collegium Medicum, Jagiellonian University
Krakow
Poland
Joanna Mika
Associate Professor, Ph.D.
Institute of Pharmacology, Polish Academy of Sciences
Krakow
Poland
Irena Nalepa
Professor, Ph.D.
Institute of Pharmacology, Polish Academy of Sciences
Krakow
Poland
Joanna Pera
Professor, Ph.D., M.D.
Collegium Medicum, Jagiellonian University
Krakow
Poland
Edmund Przegaliński
Professor, Ph.D., M.D.
Institute of Pharmacology, Polish Academy of Sciences
Krakow
Poland
Marek Sanak
Professor, Ph.D., M.D.
Collegium Medicum, Jagiellonian University
Krakow
Poland
Agnieszka Słowik
Professor, Ph.D., M.D.
Collegium Medicum, Jagiellonian University
Krakow
Poland
Umberto Spampinato
Professor, Ph.D., M.D.
Université de Bordeaux, Inserm France
Piotr Warszyński
Professor, Ph.D.
Institute of Catalysis and Surface Chemistry, Polish Academy of Sciences
Krakow
Poland

Organizing Committee




Małgorzata Filip
Małgorzata Filip

Professor, Ph.D.


Function: Chair
Institute of Pharmacology
Polish Academy of Sciences

Marek Sanak
Marek Sanak

Professor, Ph.D., M.D.


Function: Vice-Chair
Collegium Medicum
Jagiellonian University

Edmund Przegaliński
Edmund Przegaliński

Professor, Ph.D., M.D.


Function: Finance Chair
Institute of Pharmacology
Polish Academy of Sciences

Joanna Pera
Joanna Pera

Professor, Ph.D., M.D.


Function: Program Chair, Guest Speakers
Collegium Medicum
Jagiellonian University



The remaining organizers


Name Function Institution Country
Małgorzata Frankowska, Ph.D.
Company Exhibition, Sponsors Institute of Pharmacology
Polish Academy of Sciences
Poland
Magdalena Zaniewska, Ph.D.
Public Relations & Media Institute of Pharmacology
Polish Academy of Sciences
Poland
Anna Sadakierska-Chudy, Ph.D.
Publications Institute of Pharmacology
Polish Academy of Sciences
Poland
Andrew C. McCreary, Ph.D.
Company Exhibition Jenssen Prevention Center
Leiden
The Netherlands
Agata Suder
General Secretarial Duties Institute of Pharmacology
Polish Academy of Sciences
Poland
Jakub Bieńkowski
Website Administrator Not affiliated Poland

Travel


More information about available transport from Krakow Balice Airport to the City Centre can be found on Kraków.travel's website.



More information about transport from Railway Station to the City Centre can be found on Kraków.travel's website.



More information about moving around Krakow:

Important places


The most important places of the 2nd Central European Biomedical Congress are placed on the map below:

Accomodation




Participants can choose accomodation in one of these hotels:

(in alphabetical order)

  1. andel's Hotel Krakow ****, ul. Pawia 3, Kraków
  2. Best Western Plus Q ****, ul. Wygrana 6, Kraków
  3. Bursa im. St. Pigonia, ul. Garbarska 7A, Kraków
  4. Chopin ***, ul. Przy Rondzie 2, Kraków
  5. Dom Gościnny UJ, ul. Floriańska 49, Kraków
  6. Excelsior Boutique Hotel ***, ul. Piłsudskiego 23, Kraków
  7. Fortuna ***, ul. Czapskich 5, Kraków
  8. Fortuna Bis ***, ul. Piłsudskiego 25, Kraków
  9. Holiday Inn *****, ul. Wielopole 4, Kraków
  10. ibis budget Stare Miasto *, ul. Pawia 15, Kraków
  11. Maksymilian ***, ul. Karmelicka 36, Kraków
  12. Nawojka, ul. Reymonta 11, Kraków
  13. Novotel Krakow Centrum ****, ul. Kościuszki 5, Kraków
  14. Ostoya Palace ****, ul. Piłsudskiego 24, Kraków
  15. Senacki ***, ul. Grodzka 51, Kraków
  16. Wawel ***, ul. Poselska 22, Kraków
  17. Żaczek, al. 3 Maja 5, Kraków

Hotels placed on map:

Auditorium Maximum

Auditorium Maximum is the biggest Jaggielonian University's didactic and conference building. It was built in 2005 at the Krupnicza Street in Krakow's City Center. The building contains of several rooms, both in amphitheatrical and flat style. The biggest of them, Large Hall, can hold up to 1.200 people.

Registration Information


Pricing


    • Early

    • Paid before Mar 30, 2016

      • Regular fee: 1.200 PLN
      • Reduced fee*: 900 PLN
      • Accompanying Persons fee: 800 PLN
      • Gala dinner fee: 200 PLN
      • Congress Dinner included
    • Register
    • Standard

    • Paid before Jun 10, 2016

      • Regular fee: 1.400 PLN
      • Reduced fee*: 1.100 PLN
      • Accompanying Persons fee: 1.000 PLN
      • Gala dinner fee: 250 PLN
      • Congress Dinner included
    • Register
    • Late & on-site

    • Paid after Jun 10, 2016

      • Regular fee: 1.500 PLN
      • Reduced fee*: 1.200 PLN
      • Accompanying Persons fee: 1.100 PLN
      • Gala dinner fee: 260 PLN
      • Congress Dinner included
    • Register

*Junior scientists (graduate students Ph.D. students, Ph.D. fellows before the age of 35 at the time of the Congress)

Program


This is the initial program version.

Last update: June 12th, 2016

June 15, 2016
18:00 - 19:00
Registration
Venue: Manggha Museum of Japanese Art and Technology Europe - Far East Gallery
19:00 - 19:30
Welcome Addresses
Venue: Manggha Museum of Japanese Art and Technology Europe - Far East Gallery
Chairs: CEBC Organizers

Speakers:
Rector of the Jagiellonian University
Director of the Institute of Pharmacology PAS
President of the Polish Academy of Sciences
19:30 - 20:15
Inauguration Lecture
Venue: Manggha Museum of Japanese Art and Technology Europe - Far East Gallery
Plenary Lecture 1: Personalized Therapies for CNS Diseases: Needs and Approaches
Kaplana M. Merchant - Indiana University-Purdue University, USA
Chair: Joanna Pera
20:30 - 21:00
Music Performance by Marcin Wyrostek & Tango Corazon
Venue: Manggha Museum of Japanese Art and Technology Europe - Far East Gallery
21:00 - 22:30
Welcome reception
Venue: Manggha Museum of Japanese Art and Technology Europe - Far East Gallery
June 16, 2016
8:45 - 10:45
Session 1: Looking for new targets for medicinal chemistry-academic perspective
Chairs - Kenneth A. Jacobson (USA ), Katarzyna Kieć-Kononowicz (Poland )
Room: Medium Hall A
Speakers:
S.01-1 Kenneth A. Jacobson (NIDDK, NIH, USA )
G Protein-coupled receptors (GPCRs) for nucleosides and nucleotides: Structure-based ligand design and therapeutic potential
S.01-2 Christa E. Müller (University of Bonn, Germany )
A2A and A2B: closely related adenosine receptor subtypes with striking differences
S.01-3 Marcin Drąg (Wroclaw University of Technology, Wroclaw, Poland )
Design of specific chemical tools for investigation of proteolytic enzymes using unnatural amino acids
8:45 - 10:45
Session 2: From Lipids to Serotonin: Advancing toward novel therapeutics for addictive disorders
Chairs - Kathryn A. Cunningham (USA ), Małgorzata Frankowska (Poland )
Room: Medium Hall B
Speakers:
S.02-1 Christian P. Muller (University Clinic, Friedrich-Alexander-University Erlangen-Nuremberg, Germany )
Sphingolipids and the transition from depression to alcoholism
S.02-2 Kathryn A. Cunningham (University of Texas Medical Branch, Galveston, USA )
Integrating serotoninergic strategies into therapeutics for cocaine use disorder
S.02-3 Umberto Spampinato (Inserm, Université de Bordeaux, France )
Impact of serotonin2 receptor subtypes on cocaine-induced dopamine release in the medial prefrontal cortex: implications in the control of cocaine behavioral responses
S.02-4 Magdalena Zaniewska (Institute of Pharmacology PAS, Krakow, Poland )
Defining the mechanism regulating the role of serotonin in the development of ethanol addiction in animals
8:45 - 10:45
Session 3: Nanomedicine
Chairs - Vladimir P. Torchilin (USA ), Piotr Warszyński, (Poland )
Room: Small Hall
Speakers:
S.03-1 Vladimir P. Torchilin (Northeastern University, USA )
Advances in nanosystems for drug delivery
S.03-2 Krzysztof Szczepanowicz (Jerzy Haber Institute of Catalysis and Surface Chemistry, PAS, Krakow, Poland )
Synthesis and properties of polyelectrolyte-coated nanocapsules
S.03-3 Ewa Błasiak (Faculty of Biochemistry, Biophysics and Biotechnology, Jagiellonian University, Krakow, Poland )
Biocompatible polymeric nanoparticles as promising candidates for drug delivery
S.03-4 Danuta Jantas (Institute of Pharmacology PAS, Krakow, Poland )
Neuroprotective activity of (bio)polyelectrolyte-coated nanocapsules containing curcumin
S.03-5 Joanna Ślusarczyk (Institute of Pharmacology PAS, Krakow, Poland )
Evaluation of protective action of polydatin, free form and in nanocapsules, in the hippocampal organotypic cultures treated with lipopolysaccharide
8:45 - 10:45
Session 4: Young Scientist Presentation (Ph.D. students)
Chairs - Joanna Pera (Poland ), Jan Rodriguez (Poland )
Room: Seminar Room
Speakers:
S.04-1 Katarzyna Kamińska (Institute of Pharmacology PAS, Krakow, Poland )
The effect of co-treatment with risperidone and escitalopram on dopamine and serotonin level in the rat frontal cortex
S.04-2 Joanna Jastrzębska (Institute of Pharmacology PAS, Krakow, Poland )
Modeling co-existence of depression and cocaine addiction in rats: the effects of N-acetylcysteine-amide (AD4) on cocaine reward, extinction and seeking behaviorin bulbectomized rats
S.04-3 Paweł Konieczny (Jagiellonian University Medical College, Krakow, Poland )
The role of AMP-activated kinase (AMPK) in epithelial-mesenchymal transition (EMT)
S.04-4 Bogna Badyra (Jagiellonian University Medical College, Krakow, Poland )
Characterization of bone marrow-derived mesenchymal stem cells obtained from children diagnosed with hypoxic-ischemic encephalopathy
S.04-5 Sabina Lichołai (Jagiellonian University, Krakow, Poland )
Serum miR-29c as a potential biomarker for abdominal aortic aneurysm
S.04-6 Beata Sienkiewicz (Wrocław Medical University, Wrocław, Poland )
Hepatotoxicity of posaconazole oral formulation in relation to ABCB1 polymorphism among children with haematological malignances
S.04-7 Marta Napierała (University of Medical Sciences, Poznań, Poland )
The impact of prenatal tobacco exposure on the cerebral mass of the neonate
10:45 - 11:15
Coffee Break
Ground Floor
11:15 - 12:00
Plenary Lecture 2: Hereditary breast and ovarian cancers
Jan Lubinski - Pomeranian Medical University, Poland
Room: Medium Hall A+B
Chair: Marek Sanak, Poland
12:00 - 13:30
Lunch Break
Room: TBA
13:00 - 14:30
Poster Session 1
Room: Exhibition Room
14:30 - 15:15
Plenary Lecture 3: Personalizing treatment of the schizophrenia spectrum through endophenotypes, rational pharmacology, and pharmacogenomics
Herbert Y. Meltzer - Northwestern University, Chicago, USA
Room: Medium Hall A+B
Chair: Władysław Lasoń, Poland
15:15 - 15:35
Sponsor Presentation: Clinical and prophylactic Whole Genome Sequencing as the most important step towards Personalised Medicine
Anna Boguszewska-Chachulska - Genomed (Poland )
Room: Medium Hall A+B
15:35 - 16:00
Coffee Break
Ground Floor
16:00 - 18:00
Session 5: Neuroimmunological aspect of pain
Chairs - Joanna Mika (Poland )
Room: Medium Hall A
Speakers:
S.05-1 cancelled
S.05-2 Katarzyna Starowicz (Institute of Pharmacology PAS, Krakow, Poland )
Molecular basis of OA to guide the identification of new therapeutic targets
S.05-3 Michaela Kress (Medical University of Innsbruck, Austria )
Interleukin-6 and signal transducer gp130 as important regulators of neuroimmune interactions in the pain pathway
S.05-4 Joanna Mika (Institute of Pharmacology PAS, Krakow, Poland )
Pharmacological modulation of intracellular signaling pathways in microglia can attenuate neuropathic pain symptoms and enhance opioid effectiveness
16:00 - 18:00
Session 6: Novel mechanisms and mediators in allergic inflammation
Chairs - Marek Sanak (Poland )
Room: Medium Hall B
Speakers:
S.06-1 Joshua Boyce (Harvard Medical School, USA )
Molecular pathophysiology of aspirin exacerbated respiratory disease
S.06-2 Masami Taniguchi (Sagamihara National Hospital, Japan )
Eicosanoid imbalance in aspirin exacerbated respiratory disease
S.06-3 Hae-Sim Park (Ajou University School of Medicine, South Korea )
Leukotriene overproduction and platelet activation in AERD
S.06-4 Krzysztof Kowal (Medical University of Bialystok, Poland )
Concentration of selected eicosanoids in exhaled breath condensate during allergen-induced early asthmatic response
16:00 - 18:00
Session 7: Personalized medicine
Chairs - Zbigniew Gaciong (Poland ), Tomasz Grodzicki (Poland )
Room: Small Hall
Speakers:
S.07-1 Zbigniew Gaciong (Medical University of Warsaw, Poland )
Personalized or precision medicine?
S.07-2 Anna Wójcicka & Krystian Jażdżewski (Medical University of Warsaw, Poland )
Genome studies and the risk of cancer
S.07-3 Karol Kamiński (Medical University of Białystok, Poland )
One treatment for all? A case of cardiovascular patient
16:00 - 18:00
Session 8: Society of Neurotoxicity - Processes and Mechanisms Associated with Parkinson’s Disease
Chairs - Richard M. Kostrzewa (USA ), Elaine Del Bel Guimaraes (Brasil )
Room: Seminar Room
Speakers:
S.08-1 Rita Raisman-Vozari (INSERM, Brain and Spine Institute, Paris, France )
Role of antibiotics on neuroprotection and neuroinflammation
S.08-2 María-Trinidad Herrero Ezquerro (School of Medicine, University of Murcia, Murcia, Spain )
Matrix metalloproteinases and neurodegenerative progression in Parkinsonism
S.08-3 Richard M. Kostrzewa (East Tennessee State University, Johnson City, USA )
L-DOPA effect on hydroxyl radical in a Parkinsonian rat
S.08-4 Elaine Del Bel Guimaraes (University of Sao Paulo, Brasil )
NO and glutamate interaction in treatment of L-DOPA-induced dyskinesia
19:30 - 22:30
Gala Dinner
Venue: Wierzynek
Full fee
June 17, 2016
8:45 - 10:45
Session 9: Workshop for Polish young scientists - National Science Center (Poland )
Chairs - Marcin Liana (Poland ), Magdalena Kowalczyk (Poland )
Room: Seminar Room
Tips for writing a successful grant proposal
8:45 - 10:45
Session 10: Diabetes
Chair - Maciej Małecki (Poland )
Room: Medium Hall A
Speakers:
S.10-1 Benjamin Glaser (Hadassah-Hebrew University Medical Center, Israel )
Non-invasive detection of cell death in diabetes and other pathologists
S.10-2 Maciej Małecki (Jagiellonian University Medical College, Krakow, Poland )
The deadly duo of obesity and type 2 diabetes - can new drugs treat both?
S.10-3 Leszek Czupryniak (Medical University of Warsaw, Poland )
Vascular complications of diabetes – completely avoidable at last?
S.10-4 Irina Kowalska (Medical University of Białystok, Poland )
Insulin resistance - does it play a role in pathogenesis of chronic complications and treatment of diabetes?
8:45 - 10:45
Session 11: Neurodegenerative diseases
Chair - Jacek Kuźnicki (Poland )
Room: Medium Hall B
Speakers:
S.11-1 Axel Methner (University Medical Center Mainz, Mainz, Germany )
Analysis and recovery of neuronal microcircuit activity in Huntington’s disease using two-photon microscopy and optogenetics
S.11-2 Urszula Fiszer (Medical Centre of Postgraduate Training, Warsaw, Poland )
Biomarkers in Parkinson’s disease
S.11-3 Piotr Lewczuk (Universitätsklinikum Erlangen, and Friedrich-Alexander Universität Erlangen-Nürnberg, Germany )
CSF biomarkers of Alzheimer’s disease
S.11-4 Urszula Wojda & Jacek Kuźnicki (Nencki Institute of Experimental Biology, Warsaw, Poland/International Institute of Molecular and Cell Biology, Warsaw, Poland )
Blood biomarkers of Alzheimer’s disease
8:45 - 10:45
Session 12: Young Scientist Presentation (Ph.D. students)
Chair - Christa E. Müller (Germany )
Room: Small Hall
S.12-1 Stefan Mordalski (Institute of Pharmacology PAS, Krakow, Poland )
Molecular mechanism of activity of non-basic ligands of 5-HT6 receptors
S.12-2 Agnieszka Olejarz (Jagiellonian University Medical College, Krakow, Poland )
Monoamine oxidase B activity of novel xanthine derivatives
S.12-3 Dawid Warszycki (Institute of Pharmacology PAS, Krakow, Poland )
Pharmacophore modeling of UDP-N-acetylmuramoylalanine glutamate ligase inhibitors – methodology and application for virtual screening procedure
S.12-4 Joanna Laskowska (Nicolaus Copernicus University, Toruń, Poland )
Genomic and transcriptomic determinants of resistance in anthracycline therapy in pediatric acute leukemias
S.12-5 Sonia Trojan (Jagiellonian University Medical College, Krakow, Poland )
Methylation of CD146 (MCAM) gene promoter as a cause of CD146 silencing level in breast cancer cell lines
S.12-6 Katarzyna Ciaćma (Jagiellonian University Medical College, Krakow, Poland )
TRAIL-producing Lactococcus lactis bacteria as a vehicle for induction of colorectal cancer cell apoptosis
S.12-7 Ana Semeano (Universidade de São Paulo, São Paulo, Brazil )
The impact of magnetic field on ion influx of the neuronal cells
S.12-8 Magda Zychowska (Institute of Pharmacology PAS, Krakow, Poland )
The influence of BoNT/A administration on IL-1 family members in rat neuropathic pain model – in vivo and in vitro evidences
10:45 - 11:15
Coffee Break
Ground Floor
11:15 - 12:00
Plenary Lecture 4: Structural insights into G protein coupled receptor activation
Brian S. Kobilka - Stanford University, USA
Nobel Prize laureate 2012
Room: Medium Hall A+B
Chair: Krzysztof Wędzony, Poland
12:00 - 13:30
Lunch Break
Room: TBA
13:00 - 14:30
Poster Session 2
Room: Exhibition Room
14:30 - 15:15
Plenary Lecture 5: How novel should the new drug targets be? Industry perspective
Anton Bespalov - Partnership for Assessment and Accreditation of Scientific Practice, Germany
Room: Medium Hall A+B
Chairs: Irena Nalepa, Poland
15:15 - 15:30
Sponsor Presentation: Precision molecular profiling of cancer using droplet Digital™ PCR
Eddy van Colleburg - Bio-Rad (Poland )
Room: Medium Hall A+B
15:30 - 16:00
Coffee Break
Ground Floor
16:00 - 18:00
Session 13: Learning the emotions with the help of the amygdala
Chairs - Ewelina Knapska (Poland ), Leszek Kaczmarek (Poland )
Room: Medium Hall A
Speakers:
S.13-1 Leszek Kaczmarek (Nencki Institute of Experimental Biology PAS, Poland )
MMP-9, extracellular protease – a culprit of aberrant synaptic plasticity
S.13-2 Norbert Hajos (Institute of Experimental Medicine, Hungarian Academy of Sciences, Hungary )
Functional organization of perisomatic inhibition in the basolateral amygdala
S.13-3 Ewelina Knapska (Nencki Institute of Experimental Biology PAS, Poland )
Neuronal circuits in the central amygdala underlying socially transferred fear
S.13-4 Cyril Herry & Cyril Dejean (INSERM, Neurocentre Magendie & University of Bordeaux, France )
Neuronal circuits and mechanisms of fear behaviour
16:00 - 18:00
Session 14: Cerebrovascular diseases
Chairs - Agnieszka Słowik (Poland ), Jerzy Krupiński (Spain )
Room: Medium Hall B
Speakers:
S.14-1 Jerzy Krupiński (Healthcare Science Research Institute, Manchester Metropolitan University & Hospital Universitari Mútua de Terrassa, Spain )
Circulating miRNAs as future biomarkers for a cerebrovascular immune-inflammatory atherosclerotic diseases
S.14-2 Agnieszka Słowik (Jagiellonian University Medical College, Krakow, Poland )
Contemporary approach to acute stroke treatment
S.14-3 Joanna Pera (Jagiellonian University College of Medicine, Krakow, Poland )
Patients stratification in stroke management
S.14-4 Ádám Dénes (Institute of Experimental Medicine, Hungarian Academy of Sciences, Hungary )
Central and systemic inflammatory mechanisms in cerebral ischemia
16:00 - 18:00
Session 15: Environmental conditions and neuropsychiatric disorders
Chairs - Anni-Maija Linden (Finland ), Marzena Maćkowiak (Poland )
Room: Seminar Room
Speakers:
S.15-1 Juan Nacher (Universitat de Valencia, Spain )
Interneuronal plasticity and psychiatric disorders
S.15-2 Agnieszka Chocyk (Institute of Pharmacology, PAS, Poland )
Early-life stress and dysfunction of the medial prefrontal cortex as risk factors for mental disorders
S.15-3 Anni-Maija Linden (University of Helsinki, Finland )
Neuroinflammation in alcohol addiction
S.15-4 Marzena Maćkowiak (Institute of Pharmacology, PAS, Poland )
Enriched environment and development of schizophrenia-like abnormalities
16:00 - 18:00
Session 16: Structure-based drug design
Chair - Andrzej Bojarski, Poland
Room: Small Hall
Speakers:
S.16-1 David E. Gloriam (Department of Drug Design and Pharmacology, University of Copenhagen, Denmark )
Identification of endogenous and surrogate ligands for orphan GPCRs
S.16-2 Sławomir Filipek (Biological and Chemical Research Centre, University of Warsaw, Poland )
Differences of agonist and antagonist binding to GPCRs
S.16-3 György M. Keserű (Research Centre for Natural Sciences, Hungarian Academy of Sciences, Hungary )
Exploiting secondary binding pockets in aminergic GPCRs
S.16-4 Peter Kolb (Department of Pharmaceutical Chemistry, Philipps-Universität Marburg, Germany )
In silico exploration of chemical and GPCR ligand space
19:00 - 24:00
Congress Dinner
Venue: Zalesie Mansion
Basic + Full fee

Transport by bus, back and forth.

June 18, 2016
9:00 - 9:45
Plenary Lecture 6: Heteroreceptor complexes and their allosteric receptor-receptor interactions as a novel biological principle for integration of communication in the CNS: targets for drug development in mental and neurological disorders
Kjell Fuxe - Karolinska University, Sweden
Room: Medium Hall A+B
Chair: Edmund Przegaliński, Poland
9:45 - 10:15
Coffee Break
Ground Floor
10:15 - 12:15
Session 17: Property-based drug design (pharmaceutical companies’ point of view)
Chair - Małgorzata Filip, Poland
Room: Small Hall
Companies:
S.17-1 Udo Lange (Abbvie Deutschland GmbH & Co. KG, Ludwigshafen, Germany )
Competitive GlyT1 Inhibitors
Janssen
S.17-2 Charles Henry Fabritius (Selvita S.A., Poland )
Analysis of Selvita's library: generation of high quality hit compounds for our early discovery programs
S.17-3 Aleksandra Stańczak (CelonPharma, Poland )
Knowledge-based design of a novel selective pan-FGFR kinase inhibitor - CELONKO project
10:15 - 12:15
Session 18: Recent advances in the clinical applications of stem cells
Chairs - Marcin Majka (Poland ), Yang D. Teng (USA )
Room: Medium Hall A
Speakers:
S.18-1 Henning Ulrich (University of São Paulo, Brazil )
Oscillations of intracellular calcium concentration and neural transcription factor expression coding for neural fate determination of embryonic stem cells
S.18-2 Yang D. Teng (Harvard Medical School & Veterans Affairs Boston Healthcare System, USA )
Scaffolding for hMSC delivery: Defining recovery neurobiology of injured spinal cord
S.18-3 Bogusław Machaliński (Pomeranian Medical University, Poland )
Neuroprotective activity of hematopoietic stem/progenitor cells
Marcin Wysoczyński (University of Louisville, USA )
TBA
S.18-4 Piotr Musiałek (Jagiellonian University Medical College & John Paul II Hospital, Poland )
Progenitor cell imaging in cardiovascular regeneration: A need or a fancy?
10:15 - 12:15
Session 19: Potential therapeutic targets suggested by animal models of brain diseases
Chairs - Vincenzo Cestari (Italy ), Irena Nalepa (Poland )
Room: Medium Hall B
Speakers:
S.19-1 Vincenzo Cestari (Cell Biology and Neurobiology Institute & Sapienza University, Italy )
Aversive memory and its modulation in an animal model of stressor-related disorder
S.19-2 Agnieszka Zelek-Molik (Institute of Pharmacology, PAS, Poland )
Molecular adaptations of signaling pathways in animal models of addiction
S.19-3 Grzegorz Kreiner (Institute of Pharmacology, PAS, Poland )
Compensatory mechanisms as possible targets of pharmacotherapy in neurodegenerative diseases - study on transgenic models
S.19-4 Piotr Chmielarz (Institute of Biotechnology, University of Helsinki, Finland )
MicroRNAs biogenesis in Parkinson's disease - targeting DICER activity in dopamine neurons
S.19-5 Mikko Airaavara (Institute of Biotechnology, University of Helsinki, Finland )
CDNF/MANF-family of Neurotrophic Factors: biology and therapeutic potential
10:15 - 12:15
Session 20: Young Scientist Presentation (Ph.D. students)
Chairs - Marzena Maćkowiak (Poland ), Umberto Spampinato (France )
Room: Seminar Room
S.20-1 Artur Wnorowski (Medical University of Lublin, Lublin, Poland )
R,R′-4′-methoxy-1-naphthylfenoterol acts as bitopic, GPR55 + β2-adrenergic receptor, ligand in various tumor cell lines
S.20-2 Ewa Żurawska-Płaksej (Wrocław Medical University, Wrocław, Poland )
The alterations in blood plasma chitotriosidase immunoblotting pattern and O-glycans expression are associated with type 2 diabetes?
S.20-3 Marta Rusek (Medical University of Lublin, Lublin, Poland )
The impact of incretin-based drugs on some non-traditional risk factors for cardiovascular disease (CVD) in rats with fructose-induced metabolic syndrome
S.20-4 Marta Rysz (Institute of Pharmacology PAS, Krakow, Poland )
Brain serotonin regulates the expression of cytochrome liver P450 via neuroendocrine pathways involving the paraventricular and arcuate nuclei of the hypothalamus
S.20-5 Aneta Stachowicz (Jagiellonian University Medical College, Krakow, Poland )
Proteomic analysis of mitochondria isolated from the frontal cortex and hippocampus of apolipoprotein E knockout mice treated with Alda-1, an activator of mitochondrial aldehyde dehydrogenase (ALDH2)
S.20-6 Emilia Gąsińska (Medical University of Warsaw, Warszawa, Poland )
Influence of dehydroepiandrosterone on pain threshold and monoamines concentration in STZ-induced neuropathic pain model
S.20-7 Barbara Pijet (Institute of Experimental Biology PAS, Warszawa, Poland )
MMP-9 activity: friend or enemy of traumatic brain injury?
S.20-8 Katarzyna Głombik (Institute of Pharmacology PAS, Krakow, Poland )
Imipramine attenuates mitochondrial disturbances in frontal cortex- study in animal model of depression
12:15 - 13:30
Lunch Break
Room: TBA
13:30 - 14:30
Closing and Award Ceremony
Room: Medium Hall A+B

Guidelines for Presenting Authors


To all authors of either oral or poster presentations:

We prepared guideline that provides a lot of useful information.
It is divided into two main parts: Oral Presentation and Poster Presentation.

We highly encourage all presenting authors to read these guidelines.

During the CEBC congress it will be not possible to use your own laptops for lectures/oral presentations. Please have your lecture saved as PowerPoint 2010 or PDF file (slide size - standard 4:3).

Abstracts


The deadline for Abstract submission is April 15, 2016.

Prior to submitting the abstract the presenting author needs to be registered (including payment) at the Congress: www.cebc2016.com.

Abstracts should be sent to email: pub.cebc@if-pan.krakow.pl.

`

The Scientific Committee reserves the right to reject abstracts submitted in poor English, or request an immediate revision by the author. Each registered participant can submit maximum two abstracts for poster presentation. Abstracts submitted by young scientists (graduate students Ph.D. students, Ph.D. fellows before the age of 35 at the time of the Congress) will be considered for selection of a 10-min oral presentation.

Contact


All contact information is available below. Feel free to contact us!

Venue Address

33 Krupnicza Street,
Krakow,
Poland

Email

Registration and payment matters:
konferencje@uj.edu.pl

Scientific matters:
congress.cebc@if-pan.krakow.pl

Top